FUSIDIC ACID AND PROTEASE INHIBITORS
A patient taking fusidic acid with saquinavir and ritonavir developed elevated fusidic acid levels with toxicity, and elevated saquinavir and ritonavir levels (roughly 4-fold increases).
The clinical significance of this case is unclear. It has been suggested that concurrent use should be avoided.
The clinical significance of this case is unclear. It has been suggested that concurrent use should be avoided.